Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis

Genes Chromosomes and Cancer

Volumn 35, Issue 2, 2002, Pages 121-126

  Azarschab, Pia ^a   Porschen, Rainer ^b,c   Gregor, Michael ^b   Blin, Nikolaus ^a   Holzmann, Karlheinz ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Zentralkrankenhaus Bremen Ost   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL ADHESION MOLECULE; UVOMORULIN;

ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SELECTION; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPITHELIUM DYSPLASIA; GENE CONTROL; GENE SILENCING; GENETIC TRANSCRIPTION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS;

ANEUPLOIDY; CADHERINS; COLECTOMY; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC SCREENING; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PROMOTER REGIONS (GENETICS); TUMOR MARKERS, BIOLOGICAL;

EID: 0036778630     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10101     Document Type: Article

References (40)

1. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1)
2. Mutations of the human E-cadherin (CDH1) gene
3. E-cadherin as a tumor (invasion) suppressor gene
4. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors
5. E-cadherin expression in colorectal cancer: An immunocytochemical and in situ hybridization study
6. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast
7. Ulcerative colitis and colorectal cancer: A population-based study
8. Prognostic value of E-cadherin expression in 413 gastric carcinomas
9. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
10. Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centres
11. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo
12. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
13. Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis
14. Flow cytometric and histologic evaluation in a large cohort of patients with ulcerative colitis: Correlation with clinical characteristics and impact on surveillance
15. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis
16. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas
17. The interactions of APC, E-cadherin and beta-catenin in tumour development and progression
18. Ulcerative colitis and colon cancer
19. Assessment of colorectal cancer risk in patients with ulcerative colitis: Experience from a private practice
20. From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion
21. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer
22. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas
23. E-Cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma
24. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas
25. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations
26. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas
27. Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer
28. Loss of membranous E-cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stage
29. DNA aneuploidy in Crohn's disease and ulcerative colitis: Results of a comparative flow cytometric study
30. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications
31. E-Cadherin expression in squamous cell carcinomas of head and neck: Inverse correlation with tumor dedifferentiation and lymph node metastasis
32. Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterations
33. E-cadherin gene alterations are rare events in thyroid tumors
34. Cadherin cell adhesion receptors as a morphogenetic regulator
35. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas
36. Relation between aberrant alpha-catenin expression and loss of E-cadherin function in prostate cancer
37. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma
38. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer
39. Aberrant promoter methylation of multiple genes in non-small cell lung cancers